REFERENCES
- Steinberg D, Parthasarathy S, Carew T E, Khoo J C, Witztum J L. Beyond cholesterol: modification of LDL that increase atherogenicity. New Engl J Med 1989; 320: 915–924.
- Gutteridge J M C, Halliwell B. The measurement and mechanism of lipid peroxidation in biological systems. Trends Biochem Sci 1990; 15: 129–135.
- Janero D. Malondialdehyde and thiobarbituric acid-reactivity as diagnostic indices of lipid peroxidation and peroxidative tissue injury. Free Radic Biol Med 1990; 9: 515–540.
- Morrow J D, Hill K E, Burk R F, Mammour T M, Badr K F, Roberts II L J. A series of prostaglandin F2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism. Proc Natl Acad Sci USA 1990; 87: 9383–9387.
- Morrow J D, Awad J A, Boss H J, Blair I A, Roberts II L J. Non-cyclooxygenase-derived prostanoids (F2-isoprostanes) are formed in situ on phospholipids. Proc Natl Acad Sci USA 1992; 89: 10721–10725.
- Morrow J D, Awad J A, Kato T, Takahashi K, Badr K F, Robert II L J, Burk R F. Formation of novel non-cyclooxygenase-derived prostanoids (F2-isoprostanes) in carbon tetrachloride hepatotoxicity: an animal model of lipid peroxidation. J Clin Invest 1992; 90: 2502–2507.
- Nourooz-Zadeh J, Gopaul N K, Barrow S, Mallet A L Änggård E E. Analysis of F2-isoprostanes as indicators of non- enzymatic lipid peroxidation in vivo by gas chromatography- mass spectrometry: development of a solid phase extraction procedure. J Chromatogr Biomed Appl 1995; 667: 199–208.
- Gopaul N K, Anggard E E, Mallet A I, Bettridge D J, Wolff S P, Nourooz-Zadeh J. Plasma 8-epi PGF2 levels are elevated in individuals with NIDDM. FEBS Lett 1995; 368: 225–229.
- Halliwell B. Oxidative stress, nutrition and health: Experimental strategies for optimization of nutritional antioxidant intakes in humans. Free Radic Res Comm 1996; 25: 57–74.
- Chirco S, Smith C, Marchant C, Mitchinson M J, Halliwell B. Lipid peroxidation in hyperlipidaemic patients: A study of plasma using an HPLC-based thiobarbituric add test. Free Radic Res Comm 1993; 19: 51–57.
- Morrow J D, Moore K P, Awad J A et al. Marked overproduction of non-cyclooxygenase derived prostanoids (F2-isoprostanes) in the hepatorenal syndrome. J lipid Mediators 1993; 6: 417–420.
- Morrow J D, Frei B, Longmire A W et al. Increase in circulating products of lipid peroxidation (F2-isoprostanes) in smokers. New Engl J Med 1995; 332: 1198–1203.
- Frolich JC, Wilson T W, Sweetman B J et al. Urinary prostaglandins: Identification and origin. J Clin Invest 1975; 55: 763–770.
- Catella F, Nowak J, Fitzgerald G A. Measurement of renal and non-renal eicosanoid synthesis. Am J Med 1986; 81[Suppl 2B]: 23–29.
- Reilly M, Delanty N, Lawson J A, Fitzgerald G A. Modulation of oxidant stress in vivo in end stage cigarette smokers. Circulation 1996; 94: 19–25.